Matricelf Ltd (MTLF) - Total Liabilities
Based on the latest financial reports, Matricelf Ltd (MTLF) has total liabilities worth ILA2.70K ILA (≈ $7.23 USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore MTLF cash generation efficiency to assess how effectively this company generates cash.
Matricelf Ltd - Total Liabilities Trend (2019–2024)
This chart illustrates how Matricelf Ltd's total liabilities have evolved over time, based on quarterly financial data. Check MTLF cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Matricelf Ltd Competitors by Total Liabilities
The table below lists competitors of Matricelf Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Desane Group Holdings Ltd
AU:DGH
|
Australia | AU$35.11 Million |
|
ChemX Materials Ltd
AU:CMX
|
Australia | AU$3.91 Million |
|
System and Application Technologies Co. Ltd
KQ:060540
|
Korea | ₩60.83 Billion |
|
Korea SE Corp
KQ:101670
|
Korea | ₩16.53 Billion |
|
Hawthorn Resources Ltd
AU:HAW
|
Australia | AU$1.59 Million |
|
Seafresh Industry Public Company Limited
BK:CFRESH
|
Thailand | ฿2.70 Billion |
|
ProMIS Neurosciences Inc.
NASDAQ:PMN
|
USA | $12.27 Million |
Liability Composition Analysis (2019–2024)
This chart breaks down Matricelf Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Matricelf Ltd worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.69 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.33 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.25 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Matricelf Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Matricelf Ltd (2019–2024)
The table below shows the annual total liabilities of Matricelf Ltd from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ILA3.19 Million ≈ $8.54K |
-6.26% |
| 2023-12-31 | ILA3.40 Million ≈ $9.12K |
-8.11% |
| 2022-12-31 | ILA3.70 Million ≈ $9.92K |
+38.47% |
| 2021-12-31 | ILA2.67 Million ≈ $7.16K |
-14.85% |
| 2020-12-31 | ILA3.14 Million ≈ $8.41K |
+430.72% |
| 2019-12-31 | ILA591.27K ≈ $1.59K |
-- |
About Matricelf Ltd
Matricelf Ltd, a biotechnology company, develops a platform for autologous tissue engineering for various medical conditions. The company's regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson's disease, and myocardial infarction, as well as for 3D bioprinting. Matricelf Ltd was incorporated in 20… Read more